% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • edwarddpeters edwarddpeters Oct 22, 2012 12:23 PM Flag

    Where is the bottom?

    and when does Phase I results get released? Looking for $1.85 as the low before we get news. Jan. will be the 1 year anniversary of Phase II starting, you would think you would get news about phase I before phase II is fully enrolled.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ... and btw, January 2013 will be the 2 year "anniversary of phase II starting", not 1 year.

    • Don't know what you are complaining about. You will find a nice most recent phase I update for ICT-107 on the company website embedded in a worthwhile investor presentation posted Oct.'12., if you go to 'investors' and then 'webcasts&presentations'. If you look for a more 'official' release: ASCO'12 (you find the poster on the same website).

      Most remarkable: The median overall survival is an astounding 38.4 months; two patients (out of 16 = 13%) are still alive with more than 3 years of documented progressive disease; 3 patients (19%) are alive without disease progression for at least 5 years after diagnosis, 6 patients (38%) progression free for 4 years and more. See yourself!

      The proof will be in the randomized phase II trial that is fully recruited and on-going. A planned interim analysis is due Q1/Q2 2013, final results should mature in the second half of 2013.

0.208-0.0085(-3.93%)Jul 27 4:02 PMEDT